Patent Rights in Pharmaceuticals in Developing Countries
Show Less

Patent Rights in Pharmaceuticals in Developing Countries

Major Challenges for the Future

Jakkrit Kuanpoth

The book engages with a broad range of new case studies, providing a detailed examination of options for the resolution of access-to-medicine issues at global, national and local levels. In addition, the book reflects the significant progress in international and national patent law and in international policymaking in this area.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 1: Patent System Overview

Jakkrit Kuanpoth


If we did not have a patent system, it would be irresponsible, on the basis of our present knowledge of its economic consequences, to recommend instituting one. But since we have had a patent system for a long time, it would be irresponsible, on the basis of our present knowledge, to recommend abolishing it. (Fritz Machlup (1958), An Economic Review of the Patent System, Subcommittee on Patents, Trademarks and Copyrights, of the Committee on the Judiciary, 85th Cong. 2d. Sess., p. 80) I A EVOLUTION OF AN EARLY PATENT SYSTEM National Law The historical development of the patent system is a long one. The first patent statute was enacted by the Venetian State in 1474 (Mandich 1948, p. 172). It is, however, evident that an exclusive monopoly had been granted to traders or inventors as early as 500 bc (Greenstreet 1972). In England, the Crown issued monopoly rights in the form of ‘letters patent’ for the first time in 1331 to foreigners who wished to practise their craft in the country. That was the grant of monopoly privileges by King Edward III to Johannes Kempe of Flanders for the introduction of the textile industry to England (Hulme 1896; Dutton 1984). Letters patent conferred exclusive rights on such persons to sell a product or to use a process for a certain period of time. Subsequently, exclusivity under the letters patent continued to play an important part in commercial development by providing benefits to persons who introduced any new inventions or new...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.